Budesonide/eformoterol combination inhaler as maintenance and reliever treatment in asthma

Matthew Peters*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


For patients with significant asthma, the use of budesonide/eformoterol as both maintenance and reliever treatment is similarly effective to other management strategies in the achievement of good asthma control, while also reducing episodes of poor control and lessening overall treatment burden. The evidence suggests that the management of asthma should change unless there is an identifiable contraindication. Education, emphasising the sunplicity of this change in treatment, is critical to delivering the benefits. An opportunity is presented to widen the use of written asthma action plans.

Original languageEnglish
Pages (from-to)57-60
Number of pages4
JournalMedicine Today
Issue number4
Publication statusPublished - Apr 2008
Externally publishedYes


Dive into the research topics of 'Budesonide/eformoterol combination inhaler as maintenance and reliever treatment in asthma'. Together they form a unique fingerprint.

Cite this